Liabilities, Current of Icosavax, Inc. from 31 Dec 2020 to 30 Sep 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
- Summary
-
Icosavax, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2020 to 30 Sep 2023.
- Icosavax, Inc. Liabilities, Current for the quarter ending 30 Sep 2023 was $13,030,000, a 0.02% decline year-over-year.
- Source SEC data
- View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)
Icosavax, Inc. Quarterly Liabilities, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | $13,030,000 | -$3,000 | -0.02% | 30 Sep 2023 | 10-Q | 14 Nov 2023 | 2023 | Q3 |
| Q2 2023 | $15,014,000 | +$3,119,000 | +26% | 30 Jun 2023 | 10-Q | 14 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $12,901,000 | -$1,096,000 | -7.8% | 31 Mar 2023 | 10-Q | 10 May 2023 | 2023 | Q1 |
| Q4 2022 | $13,788,000 | +$4,550,000 | +49% | 31 Dec 2022 | 10-Q | 14 Nov 2023 | 2023 | Q3 |
| Q3 2022 | $13,033,000 | +$4,845,000 | +59% | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $11,895,000 | +$5,780,000 | +95% | 30 Jun 2022 | 10-Q | 15 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $13,997,000 | 31 Mar 2022 | 10-Q | 16 May 2022 | 2022 | Q1 | ||
| Q4 2021 | $9,238,000 | +$3,404,000 | +58% | 31 Dec 2021 | 10-K | 30 Mar 2023 | 2022 | FY |
| Q3 2021 | $8,188,000 | 30 Sep 2021 | 10-Q | 15 Nov 2021 | 2021 | Q3 | ||
| Q2 2021 | $6,115,000 | 30 Jun 2021 | 10-Q | 13 Sep 2021 | 2021 | Q2 | ||
| Q4 2020 | $5,834,000 | 31 Dec 2020 | 10-K | 30 Mar 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.